- Home
- CJET vs SHPH Comparison
CJET vs SHPH Comparison
Compare CJET & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CJET
- SHPH
- Stock Information
- Founded
- CJET 2009
- SHPH 2012
- Country
- CJET China
- SHPH United States
- Employees
- CJET N/A
- SHPH N/A
- Industry
- CJET Auto Manufacturing
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- CJET Consumer Discretionary
- SHPH Health Care
- Exchange
- CJET Nasdaq
- SHPH Nasdaq
- Market Cap
- CJET 2.3M
- SHPH 2.3M
- IPO Year
- CJET N/A
- SHPH 2022
- Fundamental
- Price
- CJET $0.06
- SHPH $3.13
- Analyst Decision
- CJET
- SHPH
- Analyst Count
- CJET 0
- SHPH 0
- Target Price
- CJET N/A
- SHPH N/A
- AVG Volume (30 Days)
- CJET 41.0M
- SHPH 338.9K
- Earning Date
- CJET 03-26-2026
- SHPH 11-13-2025
- Dividend Yield
- CJET N/A
- SHPH N/A
- EPS Growth
- CJET N/A
- SHPH N/A
- EPS
- CJET N/A
- SHPH N/A
- Revenue
- CJET $4,107,000.00
- SHPH N/A
- Revenue This Year
- CJET N/A
- SHPH N/A
- Revenue Next Year
- CJET N/A
- SHPH N/A
- P/E Ratio
- CJET N/A
- SHPH N/A
- Revenue Growth
- CJET N/A
- SHPH N/A
- 52 Week Low
- CJET $0.05
- SHPH $3.00
- 52 Week High
- CJET $2.99
- SHPH $56.25
- Technical
- Relative Strength Index (RSI)
- CJET 27.21
- SHPH 38.23
- Support Level
- CJET $0.09
- SHPH $3.01
- Resistance Level
- CJET $0.12
- SHPH $3.75
- Average True Range (ATR)
- CJET 0.02
- SHPH 0.41
- MACD
- CJET 0.04
- SHPH -0.10
- Stochastic Oscillator
- CJET 6.09
- SHPH 4.65
About CJET Chijet Motor Company Inc.
Chijet Motor Co Inc is engaged in the development, manufacture, sales, and service of new energy vehicles (NEV), hybrid vehicles and traditional fuel vehicles in China. New energy vehicles refer to plug-in electric vehicles, including battery electric vehicles, plug-in hybrid (PHEV) electric vehicles, and fuel cell electric vehicles. Its passenger vehicles include small cars, sedans, and sports utility vehicles, or SUVs, and commercial vehicles include light trucks and vans. The company generates all of its revenue from PRC.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.